Richard Yoon, MD
Orthopaedic Surgery · Jersey City, NJNPI 1598056699
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $385,602 of the $622,770 with a category attached, or 61.9%. 58 manufacturers reported payments, led by Stryker at 40.7% of the total. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 781 payments — averaging $797.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$254K
- Arthrex$229K
- Si-bone, Inc.$48K
- Amgen$21K
- Orthoxel Designated Activity Company$20K
- Medical Device Business Services, Inc.$14K
- plus $37K from 52 others
Across 14 payments — averaging $2193.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Si-bone, Inc.$16K
- Medical Device Business Services, Inc.$12K
- Zimmer Biomet$3K
What the payments were for
- Royalty or licence$75,19412%
- Consulting fees$385,60262%
- Speaking & faculty fees$106,36117%
- Travel & lodging$36,5686%
- Food & beverage$19,0453%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTHREX$161,207
- AXSOS$116,051
- GAMMA$89,844
- AUGMENT INJECTABLE$62,251
- T2$59,114
- HOFFMANN$55,601
- VARIAX$53,099
- PRO$34,136
- IFUSE IMPLANT SYSTEM$27,953
- PANGEA$26,532
- APEX NAILING SYSTEM$20,125
- iFuse Implant$19,146
- T2 ALPHA$16,524
- INBONE$15,330
- ASNIS$13,951
- PENNSAID$10,725
- 1788$10,232
- VMIS$8,480
- VA-LCP$8,150
- HOFFMAN$7,600
How this compares
$622,770 in reported general payments places this provider in the 95th percentile of 587 orthopaedic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 357 | $12,057 |
| Celecoxib | 18 | $1,559 |
| Diclofenac Potassium | 16 | $365 |
| Doxycycline Hyclate | 15 | $188 |
| Methylprednisolone | 22 | $157 |
| Gabapentin | 15 | $142 |
| Meloxicam | 23 | $42 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Jersey City
- Michael KellyHackensack$9.7M
- Mark HartzbandParamus$9.4M
- Randal BetzLawrenceville$3M
- Luke AustinSewell$2.9M
- Kenneth MontgomeryMorristown$2.7M
- Zachary PostEgg Harbor Township$1.7M
- Harlan LevineMontvale$1.5M
- Jeffrey AbramsPrinceton$1.5M
- Gregg KleinParamus$1.5M
- David NazarianMarlton$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.